HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation.
We have analyzed by ex vivo ELISPOT the anti-vaccinia cytotoxic T lymphocyte responses of peripheral blood mononuclear cells from humans vaccinated with Dryvax vaccine. More than 6,000 peptides from 258 putative vaccinia ORFs predicted to bind the common molecules of the HLA A1, A2, A3, A24, B7, and B44 supertypes were screened with peripheral blood mononuclear cells of 31 vaccinees. A total of 48 epitopes derived from 35 different vaccinia antigens were identified, some of which (B8R, D1R, D5R, C10L, C19L, C7L, F12, and O1L) were recognized by multiple donors and contain multiple epitopes recognized in the context of different HLA types. The antigens recognized tend to be >100 residues in length and are expressed predominantly in the early phases of infection, although some late antigens were also recognized. Viral genome regulation and virulence factor were recognized most frequently, whereas few structural proteins were immunogenic. Finally, most epitopes were highly conserved among vaccinia virus Western Reserve, variola major and modified vaccinia Ankara, supporting their potential use in vaccine and diagnostic applications.
Oseroff
Carla
C
La Jolla Institute for Allergy and Immunology, 3030 Bunker Hill Street, Suite 326, San Diego, CA 92109, USA.
Kos
Ferdynand
F
Bui
Huynh-Hoa
HH
Peters
Bjoern
B
Pasquetto
Valerie
V
Glenn
Jean
J
Palmore
Tara
T
Sidney
John
J
Tscharke
David C
DC
Bennink
Jack R
JR
Southwood
Scott
S
Grey
Howard M
HM
Yewdell
Jonathan W
JW
Sette
Alessandro
A
D000595:Amino Acid Sequence; D000956:Antigens, Viral / Q000276:immunology*; D018984:Epitopes, T-Lymphocyte / Q000032:analysis*; D015967:Gene Expression Regulation, Viral; D005814:Genes, Viral / Q000235:genetics; D006680:HLA Antigens / Q000378:metabolism*; D015395:Histocompatibility Antigens Class I / Q000378:metabolism*; D006801:Humans; D008969:Molecular Sequence Data; D010455:Peptides / Q000097:blood / Q000235:genetics / Q000378:metabolism; D012899:Smallpox / Q000517:prevention & control; D012900:Smallpox Vaccine / Q000276:immunology / Q000627:therapeutic use; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014611:Vaccination; D014615:Vaccinia / Q000276:immunology* / Q000821:virology; D014616:Vaccinia virus / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D014764:Viral Proteins / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D014774:Virulence / Q000235:genetics
D000956:Antigens, Viral; C078786:DryVax vaccine; D018984:Epitopes, T-Lymphocyte; D006680:HLA Antigens; D015395:Histocompatibility Antigens Class I; D010455:Peptides; D012900:Smallpox Vaccine; D014764:Viral Proteins